Financial statements Fibro-Lab
Balance sheet of Fibro-Lab
Company age:
Age:
4 y. 7 m. 26 d.
Share capital:
Share capital:
400 000 PLN
Balance sheet data of FIBRO-LAB
|
Year
|
2021
|
2023
|
|---|---|---|
| Total assets | 2 147 475,52 | 3 410 484,41 |
| A. Fixed assets | 812 098,93 | 1 253 274,13 |
| B. Current assets | 1 335 376,59 | 2 157 210,28 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 2 147 475,52 | 3 410 484,41 |
| A. Equity | 1 969 453,98 | 3 034 296,09 |
| B. Liabilities and provisions for liabilities | 178 021,54 | 376 188,32 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 178 021,54 | 219 555,32 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.